Answer Summary

Members discussed their experiences combining Jardiance with Vyndamax or Vyndaqel for cardiac amyloidosis, with many reporting encouraging... Read more

Members discussed their experiences combining Jardiance with Vyndamax or Vyndaqel for cardiac amyloidosis, with many reporting encouraging early results including improved shortness of breath, better sleep quality, and positive echocardiogram results showing improved ejection fraction and flow rates after several months of treatment. Several members shared that while Jardiance appeared to help with heart function and fluid management, persistent fatigue remained a challenging symptom that did not significantly improve for most. A recurring theme was cautious optimism about the combination therapy potentially slowing disease progression, though members acknowledged it was still early to draw definitive conclusions and emphasized the importance of regular monitoring through echocardiograms and blood work.